HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,206,696 | +17.9% | 267,191 | +11.3% | 0.02% | +23.1% |
| Q2 2023 | $8,657,052 | -20.6% | 240,007 | -16.0% | 0.01% | -23.5% |
| Q1 2023 | $10,909,470 | -38.1% | 285,663 | -7.8% | 0.02% | -45.2% |
| Q4 2022 | $17,627,621 | +43.6% | 309,800 | -0.2% | 0.03% | +34.8% |
| Q3 2022 | $12,275,000 | -11.0% | 310,429 | -0.9% | 0.02% | -8.0% |
| Q2 2022 | $13,785,000 | +11.1% | 313,296 | +0.7% | 0.02% | +31.6% |
| Q1 2022 | $12,406,000 | -3.6% | 311,089 | -2.8% | 0.02% | +5.6% |
| Q4 2021 | $12,866,000 | +2.2% | 319,969 | +3.4% | 0.02% | -10.0% |
| Q3 2021 | $12,593,000 | -2.9% | 309,555 | +8.4% | 0.02% | 0.0% |
| Q2 2021 | $12,971,000 | +8.9% | 285,639 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $11,908,000 | +76.9% | 285,639 | +81.2% | 0.02% | +66.7% |
| Q4 2020 | $6,732,000 | +682.8% | 157,623 | +137.5% | 0.01% | +500.0% |
| Q1 2017 | $860,000 | +16.8% | 66,359 | -10.9% | 0.00% | 0.0% |
| Q4 2016 | $736,000 | -20.4% | 74,509 | -2.7% | 0.00% | 0.0% |
| Q3 2016 | $925,000 | -15.8% | 76,602 | -39.8% | 0.00% | -33.3% |
| Q2 2016 | $1,099,000 | +37.2% | 127,328 | +50.6% | 0.00% | +50.0% |
| Q1 2016 | $801,000 | -44.2% | 84,540 | +2.1% | 0.00% | -33.3% |
| Q4 2015 | $1,435,000 | +102.1% | 82,784 | +56.6% | 0.00% | +50.0% |
| Q3 2015 | $710,000 | – | 52,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |